Impact of the 2018 Japan floods on asthma prescriptions: A longitudinal analysis

Authors: Konishi, Hanae; Yoshida, Shuhei; Iwamoto, Hiroshi; Horimasu, Yasushi; Utsumi, Shu; Ohshimo, Shinichiro; Hattori, Noboru; Matsumoto, Masatoshi

Source journal: The journal of allergy and clinical immunology. Global (2027-01-01)

DOI: 10.1016/j.jacig.2026.100792

Abstract

BACKGROUND: The impact of flood disasters on adult asthma is poorly understood. OBJECTIVE: This study aimed to investigate the impact of the 2018 Japan floods on new prescriptions for asthma controller medications and treatments for asthma exacerbations in adults. METHODS: This retrospective longitudinal analysis used data from the National Database of Health Insurance Claims and Specific Health Checkups for residents of regions severely affected by the 2018 Japan floods, covering 1 year before and 1 year after the disaster. New asthma controller prescriptions were compared between officially certified disaster victims and nonvictims with no controller use in the preceding year. Among prior controller users, prescriptions for short-acting beta (2) -agonists and oral corticosteroids were compared between victims and nonvictims. RESULTS: Among 5,000,129 participants, 31,235 were disaster victims. Victims had a higher incidence of new asthma controller prescriptions than nonvictims (adjusted hazard ratio, 1.47; 95% CI, 1.38-1.57). This increase was observed across all age groups and was greater in younger and middle-aged adults. A difference-in-differences analysis showed increased short-acting beta (2) -agonist prescriptions at 3, 5, 7, and 11 months after the disaster and increased oral corticosteroid prescriptions at 5 months among victims. CONCLUSIONS: Victims of the 2018 Japan floods had increased prescriptions for new-onset and exacerbated asthma, suggesting an association between flood disasters and increased adult asthma-related health care needs.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.